Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 1;132(7):e154944.
doi: 10.1172/JCI154944.

Next-generation sequencing: insights to advance clinical investigations of the microbiome

Affiliations
Review

Next-generation sequencing: insights to advance clinical investigations of the microbiome

Caroline R Wensel et al. J Clin Invest. .

Abstract

Next-generation sequencing (NGS) technology has advanced our understanding of the human microbiome by allowing for the discovery and characterization of unculturable microbes with prediction of their function. Key NGS methods include 16S rRNA gene sequencing, shotgun metagenomic sequencing, and RNA sequencing. The choice of which NGS methodology to pursue for a given purpose is often unclear for clinicians and researchers. In this Review, we describe the fundamentals of NGS, with a focus on 16S rRNA and shotgun metagenomic sequencing. We also discuss pros and cons of each methodology as well as important concepts in data variability, study design, and clinical metadata collection. We further present examples of how NGS studies of the human microbiome have advanced our understanding of human disease pathophysiology across diverse clinical contexts, including the development of diagnostics and therapeutics. Finally, we share insights as to how NGS might further be integrated into and advance microbiome research and clinical care in the coming years.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: CLS has received research funding to her institution from Janssen and Bristol Myers Squibb and has served on a Ferring Pharmaceuticals clinical advisory board and as a reviewer for UpToDate.

Figures

Figure 1
Figure 1. Bacterial 16S rRNA gene.
(A) Percentage sequence identity of conserved and hypervariable regions of the bacterial 16S rRNA gene. Adapted with permission from the Journal of Microbiological Methods (17) and Ilona Lehtinen (137). (B) Illustration of conserved and hypervariable regions corresponding to A and PCR amplification of the V1–V3 region of the bacterial 16S rRNA gene. Adapted with permission from Humana Press (148). (C) Schematic of 16S rRNA gene structure with hypervariable regions (V1–V9) labeled.
Figure 2
Figure 2. NGS implementation.
Overview of key steps in 16S rRNA gene sequencing, shotgun metagenomic sequencing, and RNA sequencing processes. 1Host DNA or RNA depletion can be performed (optional steps). 2PCR amplification is used to amplify bacterial 16S rRNA gene variable regions (16S rRNA amplicon sequencing) or random cDNA fragments resulting from RNA reverse transcription for RNA sequencing. DNA-based shotgun metagenomic sequencing is optimally done without use of PCR amplification to avoid introduction of PCR-associated experimental bias. However, in samples with low DNA quantities, PCR amplification of the DNA library is sometimes used. 3Commonly Illumina-based sequencing chemistry (33). 4The taxonomic and functional analyses of NGS data are complex and make use, most often, of software available in the public domain.

References

    1. Sender R, et al. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. - DOI - PMC - PubMed
    1. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16(3):463–496. doi: 10.1128/CMR.16.3.463-496.2003. - DOI - PMC - PubMed
    1. LaFond RE, Lukehart SA. Biological basis for syphilis. Clin Microbiol Rev. 2006;19(1):29–49. doi: 10.1128/CMR.19.1.29-49.2006. - DOI - PMC - PubMed
    1. Gevers D, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15(3):382–392. doi: 10.1016/j.chom.2014.02.005. - DOI - PMC - PubMed
    1. Zhou M, et al. Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing. PLoS One. 2013;8(4):e61516. doi: 10.1371/journal.pone.0061516. - DOI - PMC - PubMed

Publication types

Substances